COMP <GO>
PODD vs UNH // EV/EBITDA & P/E VALUATION
Insulet Corporation (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: PODD 8
— UNH 7
▲ EV/EBITDA & P/E VALUATION LEADER: UNH
LAST: $149.68 (-1.85%) • MKT CAP: $10.58B
valuation
17.1x
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
valuation
16.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PODD VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PODD | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 71.60% | 88.57% | -16.97 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.40% | 11.47% | +8.93 | PODD | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 17.1x | 16.4x | +0.65 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 3.57% | 6.48% | -2.91 | UNH | /fcf-yield <GO> |
| Operating Margin | 17.50% | 4.82% | +12.68 | PODD | /operating-margins <GO> |
| Net Profit Margin | 9.10% | 3.14% | +5.96 | PODD | /net-margins <GO> |
| Revenue Growth (YoY) | 30.70% | 6.46% | +24.24 | PODD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.72 | 3.12 | +2.60 | PODD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | PODD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.74% | +0.16 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.4 | 56.0 | +6.30 | PODD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 0.33 | +0.66 | PODD | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.0x | 17.1x | +18.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.58B | $364.66B | -$354.08B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PODD REV | UNH REV | PODD GROSS % | UNH GROSS % | PODD FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.71B | $447.57B | 71.6% | 88.7% | $377.7M | $16.07B |
| FY 2024 | $2.07B | $400.28B | 69.8% | 88.3% | $305.3M | $20.70B |
| FY 2023 | $1.70B | $371.62B | 44.0% | 89.6% | $69.3M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PODD // BETA 0.99
UNH // BETA 0.33